We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
-2.62%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+466.5%
AUM
$983B
AUM Growth
-$31.2B
Cap. Flow
+$4.25B
Cap. Flow %
0.43%
Top 10 Hldgs %
17.59%
Holding
7,879
New
220
Increased
3,247
Reduced
3,221
Closed
253

Sector Composition

Rank Sector Weight
1 Technology 20.54%
2 Healthcare 10.41%
3 Financials 10.2%
4 Consumer Discretionary 8.92%
5 Industrials 6.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DNA.WS
5501
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$162K ﹤0.01%
718,868
KWY
5502
Kingsway Corp
KWY
$291M
$162K ﹤0.01%
21,404
+5,688
+36% +$47.4K
SRTAW
5503
DELISTED
Strata Critical Medical Inc Warrants
SRTAW
$161K ﹤0.01%
700,000
FDBC icon
5504
Fidelity D&D Bancorp
FDBC
$317M
$161K ﹤0.01%
3,547
-1,094
-24% -$51.7K
ADAG
5505
Adagene
ADAG
$266M
$161K ﹤0.01%
105,217
+49,949
+90% +$68.4K
SCLX icon
5506
Scilex Holding
SCLX
$48.2M
$161K ﹤0.01%
3,277
+2,373
+263% +$325K
KZR
5507
DELISTED
Kezar Life Sciences
KZR
$160K ﹤0.01%
13,483
-35,650
-73% -$632K
IRS
5508
IRSA Inversiones y Representaciones
IRS
$1.25B
$160K ﹤0.01%
26,124
-118,378
-82% -$888K
LXP.PRC icon
5509
LXP Industrial Trust 6.5% Series C Preferred Stock
LXP.PRC
$94.9M
$160K ﹤0.01%
3,569
+1,067
+43% +$49.6K
VLD
5510
DELISTED
Velo3D, Inc.
VLD
$160K ﹤0.01%
2,922
-3,605
-55% -$224K
ICAD
5511
DELISTED
iCAD Inc
ICAD
$159K ﹤0.01%
75,425
+1,223
+2% +$2.91K
NODK icon
5512
NI Holdings
NODK
$312M
$159K ﹤0.01%
12,364
-1,732
-12% -$23K
ORMP icon
5513
Oramed Pharmaceuticals
ORMP
$177M
$158K ﹤0.01%
60,514
+16,724
+38% +$52.7K
OPOF
5514
DELISTED
Old Point Financial
OPOF
$156K ﹤0.01%
8,534
-300
-3% -$5.51K
AKYA
5515
DELISTED
Akoya BioSciences
AKYA
$156K ﹤0.01%
33,504
-3,716
-10% -$21.4K
EQRR icon
5516
ProShares Equities for Rising Rates ETF
EQRR
$33.3M
$156K ﹤0.01%
3,077
-3,415
-53% -$178K
IPO icon
5517
Renaissance IPO ETF
IPO
$161M
$156K ﹤0.01%
4,866
+2,881
+145% +$95.6K
SMTI icon
5518
Sanara MedTech
SMTI
$314M
$155K ﹤0.01%
4,984
-1,104
-18% -$42.8K
GMDA
5519
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$155K ﹤0.01%
150,495
+4,762
+3% +$6.08K
SGMT icon
5520
Sagimet Biosciences
SGMT
$578M
$154K ﹤0.01%
+17,464
New +$233K
SGC icon
5521
Superior Group of Companies
SGC
$209M
$154K ﹤0.01%
19,737
-22,827
-54% -$198K
DRTS icon
5522
Alpha Tau Medical
DRTS
$1.24B
$153K ﹤0.01%
40,303
MTBL
5523
DELISTED
Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares)
MTBL
$152K ﹤0.01%
151,639
-6,140
-4% -$7.64K
AENZ
5524
DELISTED
Aenza S.A.A.
AENZ
$151K ﹤0.01%
60,540
-1,600
-3% -$3.23K
OBIO icon
5525
Orchestra BioMed
OBIO
$259M
$151K ﹤0.01%
17,264
+14,236
+470% +$95.7K

Similar funds

Morgan Stanley's Q3 2023 Portfolio in Review

As of Q3 2023, Morgan Stanley held 7,879 positions worth $983B, down 3.1% from $1.01T the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Morgan Stanley's Q3 2023 filing shows 220 new, 3,247 increased, 3,221 reduced and 253 closed positions. Its largest new stake was TKO Group: 3,583,743 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.7B.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

  • Morgan Stanley's largest Q3 2023 buy was TKO Group: 3,583,743 shares worth $301M.
  • Morgan Stanley added most to iShares Core S&P 500 ETF in Q3 2023, an estimated $2.36B increase.
  • Morgan Stanley's biggest Q3 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.7B.
  • Morgan Stanley fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $432M.
  • Morgan Stanley's ten largest holdings make up 18% of its $983B portfolio in Q3 2023.
  • Morgan Stanley opened 220 new positions and closed 253 in Q3 2023.
  • Morgan Stanley's portfolio value fell 3.1% quarter-over-quarter to $983B.

Based on Morgan Stanley's 13F filing for Q3 2023, filed 15 Nov 2023.